by Cryostem | Nov 20, 2020
Members of the CRYOSTEM network were all invited on Wednesday November 18 to participate in the annual meeting of the Plenary Committee. The opportunity for participants to take stock of the national cohort and discuss the ongoing valorization actions of the... 
by Cryostem | Oct 22, 2020
CRYOSTEM and Modul-Bio are presenting a poster at the ISBER 2020 virtual symposium as part of the management of the CRYO-LEA * cohort using the MBioLIMS BioBanking® software. Launched in 2018, the CRYO-LEA cohort allows the valuation of epidemiological and clinical... 
by Cryostem | Oct 1, 2020
Inserm is now launching a platform for evaluating vaccine candidates. The planned clinical trials are on an unprecedented scale in France. Visit the COVIREIVAC platform website 
by Cryostem | Aug 31, 2020
Check Abstract A103 on the #EBMT20Virtual e-poster area Background : Even if Chimeric Antigen Receptor (CAR)-T cells therapies are a promising way to treat relapsed/refractory hematologic cancers, authorities face major issues regarding their economic impact, the... 
by Cryostem | Aug 24, 2020
Eleonora Latis, David Michonneau, Claire Leloup, Hugo Varet, Régis Peffault de Latour, CRYOSTEM Consortium, Elisabetta Bianchi, Gérard Socié, Lars Rogge – AUGUST 20, 2020 “Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD”.... 